BofA/Merrill Lynch Upgrades ResMed (RMD) to Buy

September 29, 2016 9:56 AM EDT
Get Alerts RMD Hot Sheet
Price: $69.82 +9.78%

Rating Summary:
    7 Buy, 7 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 19 | New: 11
Trade RMD Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

BofA/Merrill Lynch upgraded ResMed (NYSE: RMD) from Neutral to Buy.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $64.74 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment